Molecular selection trumps clinical selection.

Authors :: Shepherd FA
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2011 Jul 20; Vol. 29 (21), pp. 2843-4. Date of Electronic Publication: 2011 Jun 13.
Publication Year :: 2011

Subjects :: Adenocarcinoma chemistry
Adenocarcinoma genetics
Adenocarcinoma mortality
Adenocarcinoma pathology
Adenocarcinoma of Lung
Biomarkers, Tumor genetics
Carboplatin administration & dosage
Carcinoma, Non-Small-Cell Lung chemistry
Carcinoma, Non-Small-Cell Lung genetics
Carcinoma, Non-Small-Cell Lung mortality
Carcinoma, Non-Small-Cell Lung pathology
Disease-Free Survival
ErbB Receptors antagonists & inhibitors
ErbB Receptors genetics
Gefitinib
Gene Dosage
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Lung Neoplasms chemistry
Lung Neoplasms genetics
Lung Neoplasms mortality
Lung Neoplasms pathology
Mutation
Paclitaxel administration & dosage
Precision Medicine
Predictive Value of Tests
Quinazolines therapeutic use
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Treatment Outcome
Adenocarcinoma drug therapy
Antineoplastic Agents therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor analysis
Carcinoma, Non-Small-Cell Lung drug therapy
ErbB Receptors analysis
Lung Neoplasms drug therapy
Protein Kinase Inhibitors therapeutic use

Language :: English
ISSN :: 1527-7755
Volume :: 29
Issue :: 21
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 21670452
Full Text :: https://doi.org/10.1200/JCO.2011.35.9208